Latest News

Halting immune response could save brain cells after stroke

A new study in animals shows that using a compound to block the body?s immune response greatly reduces disability after a stroke. The study also showed that particular immune cells -- CD4+ T-cells produce a mediator, called interleukin (IL) -21 that can cause further damage in stroke tissue. Moreover, normal mice, ordinarily killed or disabled by an ischemic stroke, were given a shot of a compound that blocks the action of IL-21. Brain scans and brain sections showed that the treated mice suffered little or no stroke damage.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Major vascular anomalies found in brains of people with Huntington's disease

  • Genetic predisposition found for noise-induced hearing loss

  • Research Finds No Correlation between Regulatory T Cells and Survival in Glioblastoma

  • Smokers who use e-cigarettes less likely to quit, study shows

  • Adenosine receptor can activate 'off signals' for pain

  • Playing a wind instrument could help lower the risk of sleep apnea

  • Local physician recommends World Health Organization retire the term opioid substitution therapy

  • Cancer and chemobrain: Cancer diagnosis affects cognitive function

  • Forming school networks to educate 'the new mainstream'

  • Kids with ADHD must squirm to learn, study says

  •